OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: University of Oxford

1 Projects | 1 Researchers | $84,625 Invested

2009

University of Oxford

Susan Greenfield, PhD

Characterization in vivo of a newly identified peptide of potential pivotal significance to Alzheimer's disease

  • Funding Amount: $84,625
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed